Angela zhang cancer research paper
Rated 3/5 based on 226 student reviews

Angela zhang cancer research paper

Comprehensive molecular characterization of gastric adenocarcinoma. The Cancer Genome Atlas Research Network; Affiliations; Contributions; Corresponding author. Access Highly Cited Articles from Cancer Biology & Therapy 2015 Impact Factor: 2.921 (© 2016 Thomson Reuters, Journal Citation Reports®.

Comprehensive molecular characterization of human colon and rectal cancer. The Cancer Genome Atlas Network; Affiliations; Contributions; Corresponding author.

angela zhang cancer research paper

Angela zhang cancer research paper

Original Article. Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer. Sunil Verma, M.D., David Miles, M.D., Luca Gianni, M.D., Ian E. Krop, M.D., Ph.D. Background Patients with metastatic non–small-cell lung cancer have a substantial symptom burden and may receive aggressive care at the end of life. We examined the.

Access Highly Cited Articles from Cancer Biology & Therapy 2015 Impact Factor: 2.921 (© 2016 Thomson Reuters, Journal Citation Reports®. Breast Cancer: Basic and Clinical Research peer reviewed articles. Learn more about this journal, read open access articles or submit papers for publishing.

Comprehensive molecular characterization of gastric adenocarcinoma. The Cancer Genome Atlas Research Network; Affiliations; Contributions; Corresponding author.

OnlineFirst articles are published online before they appear in a regular issue of the journal. Clinical Cancer Research publishes two types of OnlineFirst articles.

OnlineFirst articles are published online before they appear in a regular issue of the journal. Clinical Cancer Research publishes two types of OnlineFirst articles. Breast Cancer: Basic and Clinical Research peer reviewed articles. Learn more about this journal, read open access articles or submit papers for publishing. Original Article. Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer. Sunil Verma, M.D., David Miles, M.D., Luca Gianni, M.D., Ian E. Krop, M.D., Ph.D. Background Patients with metastatic non–small-cell lung cancer have a substantial symptom burden and may receive aggressive care at the end of life. We examined the.


Media:

angela zhang cancer research paper